High expression of S-phase kinase-associated protein 2 (Skp2) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.
作者:
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 鳞状细胞(Carcinoma, Squamous Cell);综合疗法(Combined Modality Therapy);女(雌)性(Female);人类(Humans);免疫组织化学(Immunohistochemistry);男(雄)性(Male);中年人(Middle Aged);口腔肿瘤(Mouth Neoplasms);预后(Prognosis);S期激酶相关蛋白质类(S-Phase Kinase-Associated Proteins);存活率(Survival Rate);喃氟啶(Tegafur);尿嘧啶(Uracil)
PMID
16080478
发布时间
2013-11-21
- 浏览9
Anticancer research
2471-5页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文